Report cover image

Immunotherapy Drugs Market, By Product (Monoclonal Antibodies, Immuno Modulators, Car T-Cell Therapy, Others), By Applications (Cancer, Autoimmune & Inflammatory Diseases, Others), and By Geography (Europe, APAC, North America, Latin America, And Middle E

Publisher Coherent Market Insights
Published Aug 10, 2022
Length 150 Pages
SKU # CMI17372304

Description

Immunotherapy Drugs Market, By Product (Monoclonal Antibodies, Immuno Modulators, Car T-Cell Therapy, Others), By Applications (Cancer, Autoimmune & Inflammatory Diseases, Others), and By Geography (Europe, APAC, North America, Latin America, And Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. Immunotherapy is preferable than the old technique as it helps treat a wider range of cancer, provide long-term cancer protection, and has less side effects. Immunotherapy drugs are used to treat different types of cancers. They work by activating the immune system to mobilize the target, directing the immune system toward cancer-specific targets, and triggering a response capable of destroying cancer cells. Immunotherapy drugs enable immune system to recognize and target cancer cells, making it a universal answer to cancer, and thus, there is an increasing demand for immunotherapy drugs worldwide.

Market Dynamics:

High prevalence of cancer, increasing adoption of immunotherapy drugs, rise in demand for monoclonal antibodies and biosimilars, and frequent approvals of novel drugs are some major factors expected to drive growth of the global immunotherapy drugs market during the forecast period. For instance, immunotherapy is a class of cancer treatments that trigger the immune system to fight cancer cells, and thus, has led to an increase in the use of immunotherapy or immunotherapy drugs around the world.

In March 2022, the U.S. Food and Drug Administration (FDA) approved a novel therapy for patients with metastatic or inoperable melanoma, an aggressive type of skin cancer. Moreover, in May 2022, FDA expanded its approval for a personalized cellular therapy developed at the University of Pennsylvania’s (Penn’s) Abramson Cancer Center, this time for the treatment of adults with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. It remains the only CAR-T cell therapy approved for both adult and pediatric patients.

Key features of the study:
  • This report provides in-depth analysis of the global immunotherapy drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global immunotherapy drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Merck Group, Bristol Myers Squibb, GlaxoSmithKline, AstraZeneca, Novartis, and Janssen Pharmaceuticals, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global immunotherapy drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunotherapy drugs market.
Detailed Segmentation:
  • Global Immunotherapy Drugs Market By Product:
  • Monoclonal Antibodies
  • Immuno Modulators
  • Car T-Cell Therapy
  • Others
  • Global Immunotherapy Drugs Market By Applications:
  • Cancer
  • Autoimmune & Inflammatory Diseases
  • Others
  • Global Immunotherapy Drugs Market By Geography:
  • Europe
  • APAC
  • North America
  • Latin America
  • Middle East & Africa

Table of Contents

150 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Application
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increase in prevalence of cancer worldwide
High cost and side effects of immunotherapy
Increase in adoption of immunotherapy drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Immunotherapy Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Immunotherapy Drugs Market, By Type, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Immuno Modulators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Car T-Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Global Immunotherapy Drugs Market, By Application, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Autoimmune & Inflammatory Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Global Immunotherapy Drugs Market, By Geography, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Rest of World
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
8. Competitive Landscape
Hoffmann-La Roche AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck Group
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol Myers Squibb
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Janssen Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Immunotherapy Drugs Market” - forecast to 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us